TECON(SZ:002100) Xin Lang Cai Jing·2025-12-19 04:01Group 1 - The core viewpoint of the news is that TianKang Biological has shown a positive stock performance with a 17.06% increase year-to-date and a recent rise of 6.77% over the last five trading days, despite a slight decline of 1.72% over the past 60 days [1] - As of December 10, 2025, TianKang Biological reported a revenue of 13.61 billion yuan, representing a year-on-year growth of 4.00%, while the net profit attributable to shareholders decreased by 27.20% to 412 million yuan [2] - The company has a diversified revenue structure, with the main business income coming from pig breeding (32.20%), feed (27.51%), protein and oil processing (16.37%), corn (14.75%), veterinary medicine (5.44%), and other sources [1] Group 2 - TianKang Biological has a total market capitalization of 10.12 billion yuan, with a trading volume of 96.28 million yuan and a turnover rate of 0.96% as of December 19 [1] - The company has distributed a total of 1.89 billion yuan in dividends since its A-share listing, with 598 million yuan distributed in the last three years [3] - The number of shareholders increased to 63,300 as of December 10, 2025, with an average of 21,568 circulating shares per shareholder, a decrease of 1.15% from the previous period [2]